Archive · 4 Aug 2025
Lithuania Pioneers Space Radiation Solutions, Alzheimer's and Blindness Cures
Scientists in Lithuania are working on new medicines and technologies to solve serious health problems.
They are developing a medicine to protect astronauts from radiation in space, using special molecules to absorb the radiation.
They are also using CRISPR technology to potentially cure diseases like Alzheimer's and blindness.
Scientists are researching how the brain and eyes work to find effective treatments, especially for eye conditions that affect the elderly.
The goal is to improve health and vision, making it easier to travel in space and live longer, healthier lives.
Lithuanian scientists are developing medicine to protect astronauts from high radiation levels in space.
Professor Edvinas Orentas of Delta Biosciences is leading the research, focusing on molecules to absorb and decompose radiation.
The research aims to prevent radiation damage by using molecules that absorb radiation and break it down safely.
Lithuania is also using CRISPR technology to find cures for Alzheimer's and blindness.
Scientists are working on genetic eye diseases and aiming to improve vision in the elderly.
- Who
- Professor Edvinas Orentas, scientists at Casyzyme, and other researchers.
- What
- Lithuanian scientists are researching solutions for radiation protection and cures for Alzheimer's and blindness.
- When
- Ongoing research, with potential results expected in the future, and progress in animal models.
- Where
- Vilnius, Lithuania
- Why
- To protect astronauts from radiation, find cures for diseases, and improve the health of the elderly.
Current Challenges
Future Goals
Radiation Protection
Current Challenges
Developing safe and effective molecules to absorb and decompose radiation.
Future Goals
N/A
Alzheimer's Research
Current Challenges
Understanding the complex genetic and molecular factors that cause diseases like Alzheimer's.
Future Goals
N/A
CRISPR Delivery
Current Challenges
Developing effective methods to deliver CRISPR technology to the targeted cells.
Future Goals
N/A
- Organization
- Delta Biosciences, Casyzyme
- Location
- Vilnius, Lithuania
- Technology
- CRISPR
- Focus Areas
- Radiation protection, Alzheimer's, Blindness
- CRISPR Efficiency (animal models)
- 90%